GROUP ONE TRADING, L.P. - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 114082900. A total of 3 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q2 2022$0–1000.0%0.00%–
Q1 2022$0
-100.0%
100
-95.5%
0.00%–
Q4 2021$9,000
-97.4%
2,200
-94.0%
0.00%–
Q3 2021$342,000
-24.3%
36,800
+46.6%
0.00%
-100.0%
Q2 2021$452,000–25,100–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q2 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$00.00%
SIMPLEX TRADING, LLC 8,000$4,0000.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders